Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years

被引:30
|
作者
Wang, Chung Cheng [1 ,2 ]
Chancellor, Michael B. [4 ]
Lin, Jyh Ming [3 ]
Hsieh, Jui Hsiang [1 ]
Yu, Hong Jeng [2 ]
机构
[1] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan
[2] Natl Taiwan Univ, Dept Urol, Coll Med, En Chu Kong Hosp, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Dept Internal Med, Coll Med, En Chu Kong Hosp, Taipei 100, Taiwan
[4] William Beaumont Hosp, Dept Urol, Royal Oak, MI 48072 USA
关键词
diabetes; bladder; lower urinary tract symptom; erectile dysfunction; uroflowmetry; BENIGN PROSTATIC HYPERPLASIA; 40 YEARS OLD; SEXUAL DYSFUNCTION; PREVALENCE; EPIDEMIOLOGY; POPULATION; CYSTOPATHY; DISORDERS; MARKERS; HEALTH;
D O I
10.1111/j.1464-410X.2009.08913.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To investigate the association of type 2 diabetes mellitus (T2DM) and metabolic syndrome with lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) in Taiwanese men aged < 45 years. PATIENTS, SUBJECTS AND METHODS Voiding and erectile function in 226 men with T2DM, at one diabetes clinic, and 183 healthy men with normal fasting blood glucose levels, were compared. Participants were evaluated using the International Prostate Symptom Score (IPSS), the five-item version of the International Index of Erectile Function questionnaire (IIEF-5), and measurements of flow rate and postvoid residual urine volume. The association of metabolic syndrome with LUTS and ED was also evaluated. RESULTS The mean (sd, range) age of the patients was 38.9 (6.1, 20-45) years and the mean duration of diabetes was 2.8 (3.1, 0.5-20) years. Compared with controls, men with T2DM had a significantly mean (sd) higher IPSS, of 6.1 (5.8) vs 4.1 (4.6) (P < 0.001), an increased of odds ratio (95% confidence interval) of having moderate to severe LUTS of 1.78 (1.12-2.84) (P = 0.01), greater voiding volume of 376 (177) vs 326 (102) mL (P = 0.04), a worse IIEF-5 score of 17.3 (6.4) vs 20.0 (3.8) (P < 0.001), an increased of odds ratio of having moderate to severe ED of 3.5 (2.1-5.8) (P < 0.001) but a similar maximum flow rate and postvoid residual. The IIEF-5 score was negatively correlated with the IPSS (P < 0.0001, coefficient = -0.23, 0.35-0.11) and glycosylated haemoglobin (P = 0.02, coefficient = -0.14, 0.26-0.01). In all, 156 (69%) patients met the criteria for metabolic syndrome. The mean age, duration of diabetes, glycosylated haemoglobin, IPSS, voided volume, maximum urinary flow rate and IIEF-5 score were similar between patients with and without metabolic syndrome. CONCLUSIONS Men with T2DM and aged < 45 years had more LUTS but a similar bladder emptying function than the controls. ED was highly prevalent and was associated with the severity of LUTS. Metabolic syndrome did not aggravate the severity of LUTS, emptying function or ED in the early stage of DM.
引用
收藏
页码:1136 / 1140
页数:5
相关论文
共 50 条
  • [31] Atherosclerosis is associated with erectile function and lower urinary tract symptoms, especially nocturia, in middle-aged men
    Tsujimura, Akira
    Hiramatsu, Ippei
    Aoki, Yusuke
    Shimoyama, Hirofumi
    Mizuno, Taiki
    Nozaki, Taiji
    Shirai, Masato
    Kobayashi, Kazuhiro
    Kumamoto, Yoshiaki
    Horie, Shigeo
    PROSTATE INTERNATIONAL, 2017, 5 (02) : 65 - 69
  • [32] Small fibre pathology is associated with erectile dysfunction in men with type 2 diabetes
    Dhage, Shaishav
    Ho, Jan Hoong
    Ferdousi, Maryam
    Kalteniece, Alise
    Azmi, Shazli
    Adam, Safwaan
    Marshall, Andrew
    Jeziorska, Maria
    Donn, Rachelle
    Soran, Handrean
    Malik, Rayaz A.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (03)
  • [33] LARGE PROSTATIC CALCULI MAY WORSEN ERECTILE DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS IN MIDDLE-AGED MEN
    Kim, Sun Wook
    Cho, Yong-Hyun
    Sohn, Dong Wan
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 332 - 332
  • [34] Impact of erectile function and age in men with lower urinary tract symptoms on ejaculatory dysfunction and premature ejaculation
    Hwa, J. S.
    Kam, S. C.
    Choi, J. H.
    Do, J. M.
    Seo, D. H.
    Hyun, J. S.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2012, 24 (03) : 101 - 105
  • [35] Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    AGING MALE, 2019, 22 (01) : 12 - 19
  • [36] Albuminuria is an Independent Risk Factor of Erectile Dysfunction in Men with Type 2 Diabetes
    Chuang, Yao-Chi
    Chung, Min-Shen
    Wang, Pei-Wen
    Lee, Wei-Chia
    Chen, Chung-Dar
    Chang, Hsueh-Wen
    Yang, Kuender D.
    Chancellor, Michael B.
    Liu, Rue-Tsuan
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (04) : 1055 - 1064
  • [37] Association of Glycemic Control with Risk of Erectile Dysfunction in Men with Type 2 Diabetes
    Lu, Chih-Chen
    Jiann, Bang-Ping
    Sun, Chun-Chin
    Lam, Hing-Chung
    Chu, Chih-Hsun
    Lee, Jenn-Kuen
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (06) : 1719 - 1728
  • [38] Erectile dysfunction and lower urinary tract symptoms: prevalence and risk factors in a Hong Kong primary care setting
    Ngai, K. H.
    Kwong, Alfred S. K.
    Wong, Ann S. K.
    Tsui, Wendy W. S.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (04) : 311 - 316
  • [39] Lower Urinary Tract Symptoms, Erectile Dysfunction, and Quality of Life in Poststroke Men: A Controlled Cross-Sectional Study
    Tibaek, Sigrid
    Gard, Gunvor
    Dehlendorff, Christian
    Iversen, Helle K.
    Biering-Soerensen, Fin
    Jensen, Rigmor H.
    AMERICAN JOURNAL OF MENS HEALTH, 2017, 11 (03) : 748 - 756
  • [40] Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes
    Van Den Eeden, Stephen K.
    Sarma, Aruna V.
    Rutledge, Brandy N.
    Cleary, Patricia A.
    Kusek, John W.
    Nyberg, Leroy M.
    McVary, Kevin T.
    Wessells, Hunter
    DIABETES CARE, 2009, 32 (04) : 664 - 670